I really like this part: Another IND application! Regen identified the following milestones in the anticipated further development of dCellVax: a) Generation of human dCellVax: 2 months b) In vitro demonstration of dCellVax efficacy: 1 month c) FDA-requested toxicology: 4 months d) IND submission: 1 month